文献速递新发突发、热带与寄生虫病

登革病毒血清型特异性T细胞抑制特征

Characterization of Serotype-Specific Dengue Virus T-Cell Inhibition.
PubMed 文献 · J Infect Dis · 2025-01-01

登革病毒2型和3型(DENV-2和-3)感染比DENV-1和4型与更严重疾病结局相关,但生物学解释未明。本研究通过测量T细胞受体刺激后白介素2释放评估血清型对T细胞活化的影响,发现DENV-1和-4抑制TCR信号而DENV-2和-3不抑制,且不依赖病毒复制。包膜蛋白表达干扰近端TCR信号事件,氨基酸49-62足以抑制,55和66位关键;反向遗传学证实替换这些位点可逆转或赋予抑制能力。

要点

  • DENV-1和-4病毒颗粒及包膜蛋白抑制T细胞受体信号,DENV-2和-3不抑制。
  • 抑制不需要病毒复制,由包膜蛋白干扰近端TCR信号事件介导。
  • 包膜蛋白氨基酸49-62足以抑制TCR信号,55和66位关键。

核心结论

  • DENV-1和-4病毒颗粒及包膜蛋白通过干扰近端TCR信号削弱T细胞反应,而DENV-2和-3不抑制,可能解释不同血清型致病结局差异。

研究设计与样本

  • 在Jurkat CD4+ T细胞系中表达登革病毒包膜蛋白,测量TCR刺激后白介素2释放评估T细胞活化。
  • 通过诱变定位抑制TCR的区域,用全内反射荧光显微镜和免疫印迹表征TCR信号通路抑制,反向遗传学验证包膜蛋白定位结果。

主要发现

  • T细胞与DENV-1和-4孵育抑制TCR信号,而与DENV-2和-3孵育不抑制。
  • 抑制不需要病毒复制。
  • DENV包膜蛋白表达通过干扰近端TCR信号事件活化抑制TCR。
  • DENV-1包膜蛋白氨基酸49至62足以抑制TCR信号,氨基酸55和66关键。
  • 反向遗传学证实将DENV-2和-3的氨基酸55和66替换入DENV-1和-4可逆转TCR抑制,将DENV-1的氨基酸55和66引入DENV-2和-3可赋予TCR抑制。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dengue virus serotype 2 and 3 (DENV-2 and -3) infections are associated with more severe disease outcomes than DENV-1 and 4, though a biological explanation for this has not been identified. METHODS: DENV serotype effects on human T-cell activation were assessed by measuring T-cell receptor (TCR)-mediated interleukin 2 release following TCR stimulation. DENV envelope (env) proteins were expressed in Jurkat CD4+ T-cell lines, and regions inhibiting TCR inhibition were mapped by mutagenesis. TCR signaling pathway inhibition was characterized by total internal reflection fluorescence microscopy and immunoblot. Reverse genetics validated env mapping results. RESULTS: T-cell incubation with DENV-1 and -4 inhibited TCR signaling, whereas DENV-2 and -3 did not. Inhibition did not require viral replication. DENV env protein expression inhibited TCR by interfering with activation of proximal TCR signaling events. Amino acids (aa's) 49 to 62 of DENV 1 env were sufficient to inhibit TCR signaling, with env aa's 55 and 66 being critical. Reverse genetics confirmed that substitution of DENV-2 and -3 aa's 55 and 66 into DENV-1 and -4 reversed TCR inhibition and that DENV-1 aa's 55 and 66 introduced into DENV-2 and -3 enabled TCR inhibition. CONCLUSIONS: DENV-2 and -3 are associated with more severe clinical disease than DENV-1 and -4; however, no biological explanation for this difference has been previously identified. We found that DENV-1 and -4 viral particles and env proteins blunt T-cell responses by interfering with proximal TCR signaling, while DENV-2 and -3 do not, potentially explaining DENV pathogenic outcomes in primary and secondary infection.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Xiang J, McLinden JH, Chang Q, et al. Characterization of Serotype-Specific Dengue Virus T-Cell Inhibition. J Infect Dis. 2025. PMID: 40336275. doi:10.1093/infdis/jiaf241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。